A26
(2Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide
Find entries where: A26
is present as a standalone ligand in 2 entries
Chemical Component Summary | |
|---|---|
| Name | (2Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide |
| Synonyms | ANTIPROLIFERATIVE AGENT A771726 |
| Identifiers | (Z)-2-cyano-3-oxidanyl-N-[4-(trifluoromethyl)phenyl]but-2-enamide |
| Formula | C12 H9 F3 N2 O2 |
| Molecular Weight | 270.21 |
| Type | NON-POLYMER |
| Isomeric SMILES | C/C(=C(\C#N)/C(=O)Nc1ccc(cc1)C(F)(F)F)/O |
| InChI | InChI=1S/C12H9F3N2O2/c1-7(18)10(6-16)11(19)17-9-4-2-8(3-5-9)12(13,14)15/h2-5,18H,1H3,(H,17,19)/b10-7- |
| InChIKey | UTNUDOFZCWSZMS-YFHOEESVSA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 28 |
| Chiral Atom Count | 0 |
| Bond Count | 28 |
| Aromatic Bond Count | 6 |
Drug Info: DrugBank
| DrugBank ID | DB08880 |
|---|---|
| Name | Teriflunomide |
| Groups | approved |
| Description | Teriflunomide is the active metabolite of leflunomide, and it acts as an immunomodulatory agent by inhibiting pyrimidine synthesis. It is marketed under the name Aubagio® and is indicated for the treatment of multiple sclerosis, specifically relapsing forms. The FDA label states an important warning about the risk of hepatoxicity and teratogenicity for patients using teriflunomide. |
| Synonyms |
|
| Brand Names |
|
| Indication | Used in the treatment of relapsing forms of multiple sclerosis (MS). |
| Categories |
|
| ATC-Code | L04AA31 |
| CAS number | 163451-81-8 |
Drug Targets
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Dihydroorotate dehydrogenase (quinone), mitochondrial | MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLD... | unknown | inhibitor |
| Cytochrome P450 2C8 | MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI... | unknown | inhibitor |
| Cytochrome P450 1A2 | MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL... | unknown | inducer |
| ATP-binding cassette sub-family G member 2 | MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKS... | unknown | substrate,inhibitor |
| Solute carrier organic anion transporter family member 1B1 | MDQNQHLNKTAEAQPSENKKTRYCNGLKMFLAALSLSFIAKTLGAIIMKS... | unknown | inhibitor |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| CCDC/CSD | DOSCUM |
| PubChem | 54684141 |
| ChEBI | CHEBI:68540 |
| ChEMBL | CHEMBL973 |
| Pharos | CHEMBL973 |
